Breast Cancer Research and Treatment is a comprehensive forum dedicated to all aspects of breast cancer research. The journal's focus spans across various disciplines including surgery, radiotherapy, medical oncology, endocrinology, epidemiology, immunology and cell biology. ...
②BREAST CANCER RESEARCH AND TREATMENT的自引率处于下降状态,2023年度为2.6%。 ③BREAST CANCER RESEARCH AND TREATMENT最近五年发文量分别为420,437,530,398,360。 目前,发文量占比最大的国家为美国,我国国人发文928篇,占比5.1%。 ④综合来看,BREAST CANCER RESEARCH AND TREATMENT发文量非常可观、影响因子稳定,国...
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts ac...
自引率低,无预警风险; 期刊认可度高,93%作者愿再次投稿。 期刊信息 BREAST CANCER RESEARCH AND TREATMENT涵盖乳腺癌的多个学科,外科、医学肿瘤、内分泌学、流行病学、免疫学或细胞生物学等,由SPRINGER出版社出版,为讨论和解决乳腺癌治疗中正在进行的争议提供了一个国际平台。每年有800K+文章下载量,93%的作者可能会...
Breast Cancer Research and Treatment 2 year IF: 3.831 | 投稿到拿到初审意见平均需要43天 Breast Cancer Research and Treatment为外科医师、放疗师、肿瘤内科医生、内分泌学家、流行病学家,免疫学家及细胞生物学家提供了研究乳腺癌问题的专门...
2023年4月,Breast Cancer Research and Treatment杂志发表了一篇题为HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series(《HER2低表达状态在早期浸润...
乳腺癌研究和治疗(Breast Cancer Research And Treatment)是一本由Springer US出版的一本医学-肿瘤学学术刊物,主要报道医学-肿瘤学相关领域研究成果与实践。本刊已入选来源期刊,该刊创刊于1981年,出版周期Semimonthly。2021-2022年最新版WOS分区等级:Q2,2023年发布的影响因子为3,CiteScore指数6.8,SJR指数1.267。本刊非...
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts ...
《Breast Cancer Research and Treatment》期刊影响因子最高突破过5分，最近几年维持在3分+水平，2019年影响因子有所上升，为3.831，自引率也比较低。期刊最近几年发文量呈上升趋势，2020年总量有望突破700篇，国人发文量排名第三。期刊文章发表速度比较快，不足的是版面费偏高。以上分析仅供参考，祝您发文顺利！
Breast Cancer Research And Treatment创刊于1981年,由Springer US出版商出版,收稿方向涵盖医学 - 肿瘤学全领域,此刊是中等级别的SCI期刊,所以过审相对来讲不是特别难,但是该刊专业认可度不错,仍然是一本值得选择的SCI期刊 。平均审稿速度 约1月 ,影响因子指数3,该期刊近期没有被列入国际期刊预警名单,广大学者值得...